Promising Results for Pain and Neuroprotection
2 Sources
Studies indicate that cannabinoids may significantly alleviate chronic pain and enhance neuroprotection, expanding cannabis use in medical care.
Read articleArticles about Science
Using Cannabis Compounds to Improve Sleep
2 Sources
Cannabinoids like THC, CBD, and CBN show promise for improving sleep by interacting with the endocannabinoid system, but finding the right product and dose is crucial for avoiding unwanted side effects.
Read articleStudy Reveals CBN's Potential in Neuroprotection
2 Sources
Salk Institute researchers have discovered that CBN, a lesser-known cannabinoid with neuroprotective properties, could lead to future therapies for neurodegenerative diseases and brain injury prevention. The search for effective treatments for neurodegenerative diseases has long been a challenge, particularly as the global population ages and the prevalence of conditions like Alzheimer’s and Parkinson’s continues to rise. However, recent research from the Salk Institute offers a glimmer of hope, focusing on a lesser-known cannabinoid, cannabinol (CBN), and its potential to protect the brain against aging and neurodegeneration.
Read articleIntensified Dreams and Symptoms After Quitting
10 Sources
Unveiling marijuana withdrawal's multifaceted nature, this article explores its interplay with neurobiology, psychology, and treatment strategies for recovery.
Read articleRecently added Sources about Science
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
26min read
Despite the importance of pain as a warning physiological system, chronic neuropathic pain is frequently caused by damage in the nervous system, followed by persistence over a long period, even in the absence of dangerous stimuli or after healing of injuries.
Cannabis Treatment Reduces Chronic Nerve Pain With ‘Minimal To No Side Effects,’ New Scientific Review Finds
4min read
A newly published review of research on marijuana and chronic nerve pain concludes that treatment with cannabinoids offers “significant relief from chronic pain” with “minimal to no side effects”—potentially providing patients a “life-changing alternative” to conventional pharmaceuticals.
Cannabis and Mood Disorders
17min read
The present review will provide an overview of the neurobiology, epidemiology, clinical impact, and treatment of cannabis use disorder (CUD) in mood disorders. Patients with mood disorders including major depressive disorder (MDD) and bipolar disorder (BD) have higher rates of cannabis use, and CUD compared to the general population. Reasons for this association are not clear, nor are the putative therapeutic effects of cannabis use, or its components delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), in these illnesses. The evidence surrounding treatments for patients with this comorbidity is lacking, with more support for psychotherapeutic treatments compared with pharmacological treatments.
Cannabis use and mood disorders: a systematic review
24min read
Problematic cannabis use is highly prevalent among people with mood disorders. This underscores the need to understand the effects of cannabis and cannabinoids in this population, especially considering legalization of recreational cannabis use.
The Emerging Role of Endocannabinoids in Synaptic Plasticity, Reward, and Addiction | Frontiers Research Topic
0min read
Endocannabinoids (eCBs) regulate behavior through the central nervous system, particularly in reward and addiction pathways. While they influence synaptic plasticity, the exact mechanisms remain unclear. Emerging tech, like optogenetics, helps study eCB function.
Covered by
